Distinguished in Hereditary Neuralgic Amyotrophy

Pascal Cintas

Toulouse, FR 
Distinguished in Hereditary Neuralgic Amyotrophy
Toulouse, FR 
OverviewLocationsClinical Research

Overview

Pascal Cintas practices in Toulouse, France. Mr. Cintas is rated as a Distinguished expert by MediFind in the treatment of Hereditary Neuralgic Amyotrophy. His top areas of expertise are Cramp-Fasciculation Syndrome, Hereditary Neuralgic Amyotrophy, Primary Lateral Sclerosis, Charcot-Marie-Tooth Disease, and Bone Marrow Transplant.

His clinical research consists of co-authoring 94 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Hereditary Neuralgic Amyotrophy.

Gender
Male

Locations

Toulouse, 31059, France
Other Locations
Lille, France
Bordeaux, France
Marseille, France
Lyon, France
78, Rue Du Général Leclerc, 94270, France
Rangueuil, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Long-Term Observational Study of Translarna Safety and Effectiveness in Usual Care
Long-Term Observational Study of Translarna Safety and Effectiveness in Usual Care
Enrollment Status: Active_not_recruiting
Publish Date: March 14, 2025
Chronic Cough and Small Fiber Neuropathy
Chronic Cough and Small Fiber Neuropathy
Enrollment Status: Terminated
Publish Date: October 23, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Multicenter, Interventional, Open-label Study to Monitor the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®
A Multicenter, Interventional, Open-label Study to Monitor the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®
Enrollment Status: Completed
Publish Date: September 20, 2024
Intervention Type: Other
Study Phase: Not Applicable
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection: Consequences on the Severity of Myasthenic Syndrome and Reciprocal Impact of the Two Pathologies on Their Respective Treatments
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection: Consequences on the Severity of Myasthenic Syndrome and Reciprocal Impact of the Two Pathologies on Their Respective Treatments
Enrollment Status: Completed
Publish Date: October 06, 2023
Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing
Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing
Enrollment Status: Completed
Publish Date: July 12, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 4 Less Clinical Trials

92 Total Publications

REGISTRE SMA FRANCE: A nationwide observational registry of patients with spinal muscular atrophy in France.
REGISTRE SMA FRANCE: A nationwide observational registry of patients with spinal muscular atrophy in France.
Journal: Journal of neuromuscular diseases
Published: July 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cintas's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile